Revelation Biosciences Warrant
REVBW
12 hedge funds and large institutions have $20.9K invested in Revelation Biosciences Warrant in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
1.79% less ownership
Funds ownership: 31.11% → 29.32% (-1.8%)
14% less funds holding
Funds holding: 14 → 12 (-2)
34% less capital invested
Capital invested by funds: $31.6K → $20.9K (-$10.8K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pine Valley Investments
Marlton,
New Jersey
|
+$526 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.33K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$28 |
| 3 |
CS
Clear Street
New York
|
-$2 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LA
1
Linden Advisors
New York
| $8.86K | – | – | – |
|
|
PVI
2
Pine Valley Investments
Marlton,
New Jersey
| $3.09K | +$526 | +41,431 | +17% |
|
|
YCM
3
Yakira Capital Management
Westport,
Connecticut
| $2.62K | – | – | – |
|
4
Walleye Capital
New York
| $1.98K | – | – | – |
|
5
Walleye Trading
New York
| $1.11K | – | – | – |
|
|
CAC
6
Cowen and Company
New York
| $1.06K | – | – | – |
|
|
WAM
7
Wolverine Asset Management
Chicago,
Illinois
| $765 | – | – | – |
|
8
Jane Street
New York
| $530 | – | – | – |
|
|
PFM
9
Privium Fund Management
Amsterdam,
Netherlands
| $466 | – | – | – |
|
|
EPM
10
Equitec Proprietary Markets
Chicago,
Illinois
| $212 | – | – | – |
|
|
11
Citadel Advisors
Miami,
Florida
| $151 | -$28 | -2,220 | -13% |
|
|
PIS
12
POM Investment Strategies
Raleigh,
North Carolina
| $11 | +$13 | +1,005 | New |
|
|
13
UBS Group
Zurich,
Switzerland
| – | -$1.33K | -78,000 | Closed |
|
|
CS
14
Clear Street
New York
| – | -$2 | -100 | Closed |
|
REVBW Hedge Fund Activity: Q4 2023 in Review
12 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q4 2023, worth a combined $20.9K — down 34% from $31.6K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of REVBW and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Pine Valley Investments, adding an estimated $526. The largest seller was UBS Group, exiting entirely with an estimated $1.33K sold.
- 12 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q4 2023, down from 14 in Q3 2023.
- Funds reported $20.9K of Revelation Biosciences Warrant stock for Q4 2023, down 34% quarter-over-quarter.
- 1 fund opened new Revelation Biosciences Warrant positions in Q4 2023 and 2 closed out, a net change of -1 holder.
- The largest Revelation Biosciences Warrant buyer in Q4 2023 was Pine Valley Investments, an estimated $526 added.
- The largest Revelation Biosciences Warrant seller in Q4 2023 was UBS Group, an estimated $1.33K sold.
Based on aggregated 13F filings for Q4 2023.